US Patent

US8906887 — C7-fluoro substituted tetracycline compounds

Formulation · Assigned to Tetraphase Pharmaceuticals Inc · Expires 2030-12-28 · 5y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a compound represented by Structural Formula (A) and its pharmaceutical composition, including its therapeutic use.

USPTO Abstract

The present invention is directed to a compound represented by Structural Formula (A): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.

Drugs covered by this patent

Patent Metadata

Patent number
US8906887
Jurisdiction
US
Classification
Formulation
Expires
2030-12-28
Drug substance claim
No
Drug product claim
Yes
Assignee
Tetraphase Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.